Atrophy of breast
ICD-10 N64.2 is a billable code used to indicate a diagnosis of atrophy of breast.
Atrophy of the breast refers to the reduction in size and volume of breast tissue, which can occur due to various factors including hormonal changes, aging, or certain medical conditions. This condition is often benign and may not present with significant symptoms. However, it can be associated with other breast diseases such as mastitis, which is an infection that can lead to inflammation and changes in breast tissue. In some cases, atrophy may be linked to breast hypertrophy, where the breast tissue is excessively developed, leading to a compensatory reduction in size. Breast lumps and nipple discharge may also be present in patients with atrophy, necessitating thorough evaluation through imaging studies such as mammography or ultrasound. These imaging modalities help differentiate atrophy from other pathological conditions, ensuring accurate diagnosis and management. Understanding the underlying causes of breast atrophy is crucial for appropriate treatment and patient education.
Detailed history of breast changes, imaging results, and treatment plans.
Patients presenting with breast atrophy alongside a history of breast cancer treatment.
Ensure clear documentation of any malignancy history to avoid misdiagnosis.
Hormonal assessment results, including thyroid and reproductive hormones.
Patients with hormonal imbalances presenting with breast atrophy.
Document any hormonal therapies that may influence breast tissue changes.
Used for screening in patients with breast atrophy to rule out malignancy.
Document the reason for the mammogram and any findings.
Oncology specialists should ensure imaging is aligned with treatment plans.
Common causes include hormonal changes, aging, and certain medical treatments such as chemotherapy or radiation therapy.
